Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

PHARMACIE LEPRINCE-PENTEL : revenue, balance sheet and financial ratios

PHARMACIE LEPRINCE-PENTEL is a French company founded 14 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in GEVEZE (35850), this company of category PME shows in 2023 a net income positive of 109 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMACIE LEPRINCE-PENTEL (SIREN 537570822)
Indicator 2023 2022 2021 2020 2019 2018 2017 2016 2015
Revenue N/C N/C N/C N/C N/C N/C N/C N/C N/C
Net income 109 422 € 104 059 € 82 764 € 160 205 € 117 814 € 104 422 € 134 754 € 137 624 € 135 180 €
EBITDA N/C N/C N/C N/C N/C N/C N/C N/C N/C
Net margin N/C N/C N/C N/C N/C N/C N/C N/C N/C

Revenue and income statement

In 2023, PHARMACIE LEPRINCE-PENTEL generates positive net income of 109 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2015-2023: 135 k€ -> 109 k€.

Net income (2023) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

109 422 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 35%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 63%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2023) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

35.075%

Financial autonomy (2023) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

63.223%

Asset age ratio (2023) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

29.0%

Solvency indicators evolution
PHARMACIE LEPRINCE-PENTEL

Sector positioning

Debt ratio
35.08 2023
2021
2022
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Good -6 pts over 3 years

In 2023, the debt ratio of PHARMACIE LEPRINCE-PENTEL (35.08) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
63.22% 2023
2021
2022
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Good

In 2023, the financial autonomy of PHARMACIE LEPRINCE-PENTEL (63.2%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 132.78. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2023) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

132.781

Liquidity indicators evolution
PHARMACIE LEPRINCE-PENTEL

Sector positioning

Liquidity ratio
132.78 2023
2021
2022
2023
Q1: 135.23
Med: 189.76
Q3: 270.17
Watch -27 pts over 3 years

In 2023, the liquidity ratio of PHARMACIE LEPRINCE-PENTEL (132.78) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.

Positioning of PHARMACIE LEPRINCE-PENTEL in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 220 transactions of similar company sales in 2023, the value of PHARMACIE LEPRINCE-PENTEL is estimated at 1 291 122 € (range 785 193€ - 1 815 028€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2023
220 transactions
785k€ 1291k€ 1815k€
1 291 122 € Range: 785 193€ - 1 815 028€
NAF 5 année 2023

Valuation method used

Net Income Multiple
109 422 € × 11.8x = 1 291 122 €
Range: 785 193€ - 1 815 028€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE LEPRINCE-PENTEL with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PHARMACIE LEPRINCE-PENTEL

What is the revenue of PHARMACIE LEPRINCE-PENTEL ?

The revenue of PHARMACIE LEPRINCE-PENTEL is not publicly disclosed (confidential accounts filed with INPI).

Is PHARMACIE LEPRINCE-PENTEL profitable?

Yes, PHARMACIE LEPRINCE-PENTEL generated a net profit of 109 k€ in 2023.

Where is the headquarters of PHARMACIE LEPRINCE-PENTEL ?

The headquarters of PHARMACIE LEPRINCE-PENTEL is located in GEVEZE (35850), in the department Ille-et-Vilaine.

Where to find the tax return of PHARMACIE LEPRINCE-PENTEL ?

The tax return of PHARMACIE LEPRINCE-PENTEL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE LEPRINCE-PENTEL operate?

PHARMACIE LEPRINCE-PENTEL operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.